Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%
M&A / Property

Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care

By The Northwire Desk — AI Analysis Jan 08, 2026 · 08:00 AIDR · 0.75 Rocket Doctor AI Inc.
AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. completed the acquisition of Alea Health Holdings Ltd., issuing cash and 285,712 common shares as consideration.
  • The transaction also includes repayment of a US $180,000 SAFE Note in monthly installments, with the first payment made at closing.
  • Integration of Alee’s technology is expected to enhance Rocket Doctor AI’s AI‑driven clinical workflow and expand access to physician‑led digital health services across North America.

Key Details

  • Consideration Paid:
  • US $15,000 cash (previously paid as a deposit).
  • 285,712 Rocket Doctor AI common shares issued to Alea shareholders at a deemed value of CAD $0.70 per share.
  • SAFE Note Assumption:
  • Principal balance of US $180,000 to be repaid in equal monthly installments of US $22,500 until fully satisfied.
  • First installment paid concurrently with the closing of the transaction.
  • Share Issuance Terms:
  • Shares issued under National Instrument 45‑106 prospectus exemptions; subject to a statutory hold period of four months and one day.
  • Consideration shares placed in escrow with a 28‑month release schedule – 20 % released every four months beginning on the first anniversary of closing.
  • No Long‑Term Liabilities Assumed: Apart from the SAFE Note, Rocket Doctor AI did not assume any other long‑term liabilities of Alea.
  • Strategic Rationale: Acquisition adds complementary AI and decision‑support capabilities, strengthening Rocket Doctor AI’s platform for physician‑led virtual/hybrid care and expanding service reach to underserved communities in Canada and the United States.

Notable Quotes

“This acquisition represents an important step forward in executing our strategy to build a scalable, physician‑led digital health ecosystem,” – Dr. Essam Hamza, CEO, Rocket Doctor AI.

“Joining Rocket Doctor AI allows Alea’s technology to scale within a broader clinical and operational framework that is deeply aligned with our original mission,” – Richard Dallala, Founder & CEO, Alea Health.

Read the original news release →

More from Rocket Doctor AI Inc.

Jun 30, 2026 · 08:00

Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members

M&A / Property Jun 23, 2026 · 08:00

AI-driven telemedicine platform expanding U.S. payer network, but burning cash with a going concern warning.

M&A / Property Jun 18, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer network, but burning cash and diluting equity to fund marketing.

M&A / Property Jun 16, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer access while burning cash to fund growth and R&D.

Other Jun 08, 2026 · 08:00

Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally telev

M&A / Property Jun 02, 2026 · 08:00

AI Virtual Care Platform Accelerates U.S. Visits and Secures Cash Runway, But Margin Compression and Going Concern Doubts Loom

Earnings